This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
Ghanizadeh A. , Sahraeizadeh A. , Berk M. (2014)
Child Psychiatry and Human Development
45(2), pp. 185-192.
Minerva Pediatrics
60(1), pp. 87-101
Hellings J. A. et al. (1996)
Sertraline response in adults with mental retardation and autistic disorder
Journal of Clinical Psychiatry
57(8), pp. 333-336
Hilty D. M. , Rodriguez G. D. , Hales R. E. (1998)
Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders.
Journal of Neuropsychiatry and Clinical Neurosciences
10(3), pp. 365-366
King B. H. et al. (2001)
Journal of the American Academy of Child and Adolescent Psychiatry
40(6), pp. 658-665
Kolmen B. K. et al. (1995)
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
Journal of the American Academy of Child and Adolescent Psychiatry
34(2), pp. 223-231
LeLord G. , Callaway E. , Muh J. (1982)
Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children.
Acta Vitaminologica et Enzymologica
4(1), pp. 27-44
Open-label quetiapine in the treatment of children and adolescents with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
9(2), pp. 99-107
Martineau J. , Barthélémy C. , LeLord G. (1986)
Long-term effects of combined vitamin B6-magnesium administration in an autistic child.
Biological Psychiatry
21(5), pp. 511-518
Martineau J. et al. (1985)
Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.
Biological Psychiatry
20(5), pp. 467-478
CNS Drugs
23(6), pp. 511-521
Mazzone L. et al. (2014)
Catatonia in patients with autism: Prevalence and management.
CNS Drugs
March, 28(3), pp. 205-215.
McDougle C. J. , Kem D. , Posey D. J. (2002)
Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
Journal of the American Academy of Child and Adolescent Psychiatry
41(8), pp. 921-927
O'Neill J. et al. (2010)
The SCERTS model: Implementation and evaluation in a primary special school.
Good Autism Practice
11(1), pp. 7-15.
Scahill L. , Koenig K. (1999)
Pharmacotherapy in children and adolescents with pervasive developmental disorders.
Journal of Child and Adolescent Psychiatric Nursing
12(1), pp. 41-43
Solomon L. , Peltz L. (2008)
Separation, autism, and residential treatment.
Journal of the Canadian Academy of Child and Adolescent Psychiatry
17(1), pp. 26-28
Psychosomatic Medicine
61(5), pp. 651-665
Yarbrough E. et al. (1987)
Effects of fenfluramine on autistic individuals residing in a state developmental center.
Journal of Autism and Developmental Disorders
17(3), pp. 303-314